Spero Therapeutics Statistics
NASDAQ: SPROHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.742-0.0843 (-10.20%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Spero Therapeutics by the numbers
Spero Therapeutics has a market capitalization of $43.2 million based on 58.26M shares outstanding. With trailing EPS of $-0.50, Spero Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 33.0% below its 50-day average and 60.6% below its 200-day average.
Average daily trading volume is 530.46K shares, or about $393,599 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SPRO valuation vs. peer median
| Metric | SPRO | Peer median | Difference |
|---|---|---|---|
| Market cap | $43.23M | $42.88M | +1% |
| Avg. volume | 530.46K | 636.44K | -17% |
Peer median across 8 companies: RLYB, CRBP, ANVS, INCR, OSTX, GANX, QUCY, BMEA.
Valuation
- Market cap
- $43.23M
- Price / sales (latest FY)
- 0.65
- EPS (TTM)
- $-0.50
- Shares outstanding
- 58.26M
Price and trading
- Previous close
- 0.8263
- Open
- 0.81
- Day range
- 0.7301 – 0.81
- 52-week range
- 0.73 – 3.08
- 52-week change
- -67.88%
- Beta
- —
- Volume
- 424.81K
- Average volume
- 530.46K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 43.23M
- Forward Pe
- -0.76
- Eps
- -0.50
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.08
- Week52 Low
- 0.73
- Avg Volume
- 530.46K
- Shares Outstanding
- 58.26M
- Ma50
- 1.11
- Ma200
- 1.88
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -75.91%
- Pct From52w Low
- 1.64%